Literature DB >> 30242759

Imaging Lymphatics in Mouse Lungs.

Peter Baluk1, Donald M McDonald2.   

Abstract

Lymphatic malformations and other conditions where lymphatic function is disturbed in the respiratory tract present diagnostic and therapeutic challenges. Advances in lymphatic development, growth regulation, function, and imaging have increased the understanding of lymphatics, but the airways and lungs have not received as much attentions as many other organs. The lung presents challenges for studies of lymphatics because of the complex, densely packed three-dimensional architecture of the airways and vasculature, and because it cannot readily be examined in its entirety. To address this problem, we developed methods for immunohistochemical examination of the lymphatics in mouse lungs, based on approaches we devised for lymphatic vessels and blood vessels in whole mounts of the mouse trachea. This report provides a practical guide for visualizing by fluorescence and confocal microscopy the lymphatics in mouse airways and lungs under normal conditions and in models of disease. Materials and methods are described for immunohistochemical staining of lymphatics in whole mounts of the mouse trachea and 200-μm sections of mouse lung. Also described are mouse models in which lymphatics proliferate in the lung, blocking antibodies for preventing lymphatic growth, methods for fixing mouse lungs by vascular perfusion, and techniques for staining, visualizing, and analyzing lymphatic endothelial cells and other cells in the lung. These methods provide the opportunity to learn as much about lymphatics in the lung as in other organs.

Entities:  

Keywords:  Confocal microscopy; Endothelial cells; Fluorescence microscopy; Immunohistochemistry; Lung disease; Lymphatic vessels; Mouse models; Respiratory tract

Mesh:

Substances:

Year:  2018        PMID: 30242759      PMCID: PMC6501193          DOI: 10.1007/978-1-4939-8712-2_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Lymphatic Proliferation Ameliorates Pulmonary Fibrosis after Lung Injury.

Authors:  Peter Baluk; Ram P Naikawadi; Shineui Kim; Felipe Rodriguez; Dongwon Choi; Young-Kwon Hong; Paul J Wolters; Donald M McDonald
Journal:  Am J Pathol       Date:  2020-10-08       Impact factor: 4.307

2.  Analyzing Lymphatic Vessel Patterning in Adult Tissue.

Authors:  Louise A Johnson
Journal:  Methods Mol Biol       Date:  2022

3.  ADAM8 signaling drives neutrophil migration and ARDS severity.

Authors:  Catharina Conrad; Daniela Yildiz; Simon J Cleary; Andreas Margraf; Lena Cook; Uwe Schlomann; Barry Panaretou; Jessica L Bowser; Harry Karmouty-Quintana; Jiwen Li; Nathaniel K Berg; Samuel C Martin; Ahmad Aljohmani; S Farshid Moussavi-Harami; Kristin M Wang; Jennifer J Tian; Mélia Magnen; Colin Valet; Longhui Qiu; Jonathan P Singer; Holger K Eltzschig; Wilhelm Bertrams; Susanne Herold; Norbert Suttorp; Bernd Schmeck; Zachary T Ball; Alexander Zarbock; Mark R Looney; Jörg W Bartsch
Journal:  JCI Insight       Date:  2022-02-08

4.  Pathological MAPK activation-mediated lymphatic basement membrane disruption causes lymphangiectasia that is treatable with ravoxertinib.

Authors:  Harish P Janardhan; Karen Dresser; Lloyd Hutchinson; Chinmay M Trivedi
Journal:  JCI Insight       Date:  2022-09-08

5.  Lung lymphatic thrombosis and dysfunction caused by cigarette smoke exposure precedes emphysema in mice.

Authors:  Barbara D Summers; Kihwan Kim; Cristina C Clement; Zohaib Khan; Sangeetha Thangaswamy; Jacob McCright; Katharina Maisel; Sofia Zamora; Stephanie Quintero; Alexandra C Racanelli; David Redmond; Jeanine D'Armiento; Jisheng Yang; Amy Kuang; Laurel Monticelli; Mark L Kahn; Augustine M K Choi; Laura Santambrogio; Hasina Outtz Reed
Journal:  Sci Rep       Date:  2022-03-23       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.